Table 2.

Outcomes of non-operated patients at the end of the study period

	Clinical deterioration and radiological progression	Clinical deterioration without radiological progression	Radiological progression without clinical deterioration	New-onset disease, non-related to COVID-19	Non-deterioration	Death
Oncology	1 (1.7%)	2 (3.4%)	0	1 (1.7%)	53 (91.4%)	1 (1.7%)
Degenerative spine	12 (2.6%)	110 (23.4%)	5 (1.1%)	16 (3.4%)	326 (69.4%)	1 (0.2%)
TBI	0	1 (20%)	0	0	4 (80%)	0
Haemorrhagic cerebrovascular disease	1 (5.9%)	0	0	3 (17.6%)	13 (76.5%)	0
CSF	0	10 (40%)	0	2 (8%)	13 (52%)	0
Functional	0	34 (39.5%)	0	3 (3.5%)	49 (57%)	0
Traumatic spine disease	0	1 (16.7%)	0	1 (16.7%)	4 (66.7%)	0
Infectious	0	0	1 (50%)	0	1 (50%)	0
Paediatric	0	1 (0.1%)	0	0	10 (90.9%)	0

CSF, cerebrospinal fluid; TBI, traumatic brain injury.